🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2750
-0.0143 (-4.94%)
At close: Nov 19, 2026, 4:00 PM EST
0.2870
+0.0120 (4.36%)
After-hours: Nov 19, 2026, 7:30 PM EST

Mereo BioPharma Group Revenue

Mereo BioPharma Group had revenue of $800.00K in the quarter ending September 30, 2026. This brings the company's total for the last twelve months to $800.00K, up 60.00% year-over-year. In the year 2025, Mereo BioPharma Group had annual revenue of $500.00K.

Revenue (ttm)
$800.00K
Revenue Growth
+60.00%
P/S Ratio
57.26
Revenue / Employee
$20,513
Employees
39
Market Cap
43.92M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025500.00K--
Dec 31, 2024---
Dec 31, 202310.00M--
Dec 31, 2022---
Dec 31, 202149.37M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Actinium Pharmaceuticals35.00M
MindWalk Holdings11.57M
ImageneBio800.00K
Clene238.00K
MiNK Therapeutics200.00K
Revenue Rankings